Singular Genomics SystemsOMIC

13F holders, Q3 2024 (September 30)
22holders −2
3new positions
5sold out
$15.67avg. 13F price*

At the end of Q3 2024, 22 institutions reported holding Singular Genomics Systems Inc. (OMIC) in their 13F filings, down 2 from Q2 2024. 3 opened new positions and 5 sold out. The largest holders were Tang Capital Management LLC ($5.8M), Deerfield Management Company, L.P. ($2.6M) and ARCH Venture Management, LLC ($2.0M).

Company
Singular Genomics Systems Inc.
CUSIP
82933R308
Latest filing quarter
Q4 2024

History

Number of 13F holders

0510152025 Q2 2024: 24Q2 2024Q3 2024: 22Q3 2024Q4 2024: 20Q4 2024

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions3$8.6M
Exits5$526K

All 13F filers, Q2 2024 → Q3 2024: 552,440 shares bought and 82,585 shares sold, net +469,855 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 22 holders

Tang Capital Management LLC 0.42% New 372,000 $5.8M
Deerfield Management Company, L.P. 0.04% No change 166,162 $2.6M
ARCH Venture Management, LLC 0.76% No change 126,630 $2.0M
CRCM LP 1.03% New 101,100 $1.6M
QVIDTVM Management LLC 0.92% No change 83,558 $1.3M
UBS Group AG 0.00% New 77,984 $1.2M
FMR LLC 0.00% No change 70,653 $1.1M
Vanguard Group Inc. 0.00% Add +0.0% 62,418 $978K
Perceptive Advisors LLC 0.02% Reduce -28.2% 50,896 $798K
Geode Capital Management, LLC 0.00% Add +7.1% 17,962 $282K
HighTower Advisors, LLC 0.00% No change 17,607 $276K
BlackRock, Inc. 0.00% — 15,734 $247K
Tikvah Management LLC 0.05% No change 10,561 $165K
Barclays PLC 0.00% No change 409 $6K
Bank of America Corp. 0.00% Add +0.5% 369 $6K
Morgan Stanley 0.00% Reduce -15.4% 307 $5K
Tower Research Capital LLC (TRC) 0.00% Reduce -46.8% 281 $4K
JPMorgan Chase & Co. 0.00% Add +800.0% 180 $3K
Dynamic Wealth Strategies, LLC 0.00% No change 56 $1K
Royal Bank of Canada 0.00% Reduce -23.0% 67 $1K
BNP Paribas Financial Markets 0.00% No change 36 $564
Harbour Investments, Inc. 0.00% No change 5 $78

"% of holder's portfolio" is OMIC's weight in each manager's 13F, not the share of Singular Genomics Systems Inc. the manager owns.